EP 1499298 A1 20050126 - ORAL ADMINISTRATION FORM FOR DIFFICULTY SOLUBLE BASIC ACTIVE INGREDIENTS WHICH ARE APPLIED ORALLY
Title (en)
ORAL ADMINISTRATION FORM FOR DIFFICULTY SOLUBLE BASIC ACTIVE INGREDIENTS WHICH ARE APPLIED ORALLY
Title (de)
ORAL ZU APPLIZIERENDE DARREICHUNGSFORM FÜR SCHWERLÖSLICHE BASISCHE WIRKSTOFFE
Title (fr)
FORME D'ADMINISTRATION ORALE POUR PRINCIPES ACTIFS BASIQUES DIFFICILEMENT SOLUBLES
Publication
Application
Priority
- DE 10209982 A 20020307
- EP 0302184 W 20030304
Abstract (en)
[origin: WO03074032A1] The invention relates to a novel, oral administration form for active ingredients exhibiting pH-dependent solubility characteristics and the pharmacological compatible salts thereof, which improves the bioavailability of the active ingredient thereof.
IPC 1-7
IPC 8 full level
A61K 9/16 (2006.01); A61K 9/26 (2006.01); A61K 9/50 (2006.01); A61K 31/4439 (2006.01); A61K 47/12 (2006.01); A61K 47/18 (2006.01); A61K 47/32 (2006.01); A61K 47/36 (2006.01); A61K 47/38 (2006.01); A61P 7/02 (2006.01)
CPC (source: EP US)
A61K 9/1676 (2013.01 - EP US); A61K 9/5078 (2013.01 - EP US); A61K 31/4439 (2013.01 - EP US); A61K 31/496 (2013.01 - EP US); A61P 7/02 (2017.12 - EP)
Citation (search report)
See references of WO 03074032A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 03074032 A1 20030912; AU 2003229555 A1 20030916; BR 0308188 A 20041221; DE 10209982 A1 20030925; EP 1499298 A1 20050126; EP 1818047 A2 20070815; EP 1818047 A3 20080806; JP 2005526738 A 20050908; ME P43508 A 20110210; NO 20043998 L 20041005; RS 77904 A 20061027; US 2005095293 A1 20050505
DOCDB simple family (application)
EP 0302184 W 20030304; AU 2003229555 A 20030304; BR 0308188 A 20030304; DE 10209982 A 20020307; EP 03722336 A 20030304; EP 07108392 A 20030304; JP 2003572552 A 20030304; ME P43508 A 20030304; NO 20043998 A 20040923; US 93414004 A 20040903; YU P77904 A 20030304